Mr. Mark R. Willig

• 
  www.sec.gov/Archives/edgar/data/1123333/0001047469-04-0 - [Cached Version]
  Published on: 4/26/2004    Last Visited: 7/28/2004  

  Mark R. Willig
  ...
  Mark R. Willig has served as Vice President, Sales since July 2002.Prior to joining Specialty, Mr. Willig served as Vice President of Sales at Myriad Genetics from 1997 to July 2002.He also served as Vice President of Sales and Marketing for Orca Medical Systems from 1995 to 1997.During his tenure from 1984 to 1995 at Abbott Diagnostics, a division of Abbott Laboratories, Mr. Willig held a variety of field sales and sales management responsibilities, including leadership of Abbott's integrated health systems sales force.Mr. Willig received his B.A. in Speech Communications from the University of Missouri.

• 
  www.corporate-ir.net/ireye/ir_site.zhtml?ticker=SP&scri - [Cached Version]
  Published on: 7/23/2002    Last Visited: 10/9/2004  

  Specialty Laboratories Names New Vice President of Sales; Mark R. Willig to Lead Sales Expansion in the Hospital MarketSpecialty Laboratories Investor Relations
  ...
  Specialty Laboratories Names New Vice President of Sales; Mark R. Willig to Lead Sales Expansion in the Hospital Market
  
  SANTA MONICA, Calif., Jul 23, 2002 (BUSINESS WIRE) -- Specialty Laboratories, Inc. (NYSE:SP) (Specialty), a leading research-driven clinical reference laboratory, announced today the appointment of Mark R. Willig to the position of Vice President, Sales.The appointment supports Specialty's current focus on revitalizing its leadership position in the hospital market following the resolution of regulatory sanctions announced on July 17, 2002.
  
  Willig, 43, is a seasoned sales-professional with nearly two decades of experience in the diagnostics and clinical reference laboratory industries.As Vice President of Sales at Myriad Genetics from 1997 until joining Specialty, Willig developed and managed a national field sales organization charged with the promotion of esoteric gene-based tests for predisposition to cancer and other diseases.From 1995 to 1997 he served as Vice President of Sales and Marketing for Orca Medical Systems, a hospital information technology company.During his tenure from 1984 to 1995 at Abbott Diagnostics, a division of Abbott Laboratories, Willig held a variety of field sales and sales management responsibilities, including leadership of Abbott's integrated health systems sales force.
  ...
  "My decision to join the Specialty team was directly influenced by the company's wholly esoteric focus, excellence in new assay development and proprietary solutions for client connectivity," noted Willig.

• 
  Cleveland Clinic Foundation: Information on Makeup - [Cached Version]
  Published on: 3/29/2005    Last Visited: 9/26/2006  

  PrognostiX, a start-up company established by the Cleveland Clinic, named Mark R Willig as its new CEO.http://www.myHealthcareNews.com
  
  Cleveland Clinic Health System-East Region Selects Pathlore Training Solution

• 
  Cleveland Clinic Spin-Off Names New CEO - [Cached Version]
  Published on: 7/14/2005    Last Visited: 7/14/2005  

  CLEVELAND, July 13 /PRNewswire/ -- PrognostiX, a start-up company established by the Cleveland Clinic, has named Mark R. Willig as its new CEO.
  
  Mr. Willig assumes his post July 18.He joins PrognostiX a month after the company received approval from the U.S. Food and Drug Administration to begin selling a diagnostic test capable of identifying patients in imminent danger of heart attack or death.
  ...
  "The Board of Directors believes that Mark Willig is exactly the right person to lead and accelerate this process.We were very fortunate to have been able to recruit him to Cleveland."
  
  Mr. Willig most recently was Senior Vice President of Sales and Marketing for Specialty Labs Inc., a leading clinical reference laboratory that performs advanced clinically useful testing services for hospitals, laboratories and physician-specialist communities nationwide.The company, which trades on the New York Stock Exchange, is based in Valencia, Calif., and reported net revenues of $134.8 million for the year ending Dec. 31, 2004.
  
  "I am pleased to join PrognostiX at a time when the company has exciting new products in the development pipeline," Mr. Willig said.

• 
  Marc Golub Photography & Digital Services Inc. - [Cached Version]
  Published on: 9/29/2004    Last Visited: 9/27/2005  

  Mark Willig, President & CEO of Prognostix, a CCF Inovations Company

• 
  PharmaLive - [Cached Version]
  Published on: 11/6/2001    Last Visited: 8/5/2002  

  Specialty Laboratories Names New Vice President of Sales; Mark R. Willig to Lead Sales Expansion in the Hospital Market [more]
  
  Dorland Sweeney Jones Announces Major Changes [more]
  
  GeneMax Corp.Announces Director and Officer Appointments [more]

• 
  Pharmacy Choice - News - Front Page Healthcare News -... - [Cached Version]
  Published on: 9/13/2004    Last Visited: 12/21/2005  

  CLEVELAND , July 13 /PRNewswire/ -- PrognostiX, a start-up company established by the Cleveland Clinic, has named Mark R. Willig as its new CEO.Mr. Willig assumes his post July 18 .

• 
  PrognostiX - Management Team - [Cached Version]
  Published on: 2/22/2007    Last Visited: 2/22/2007  

  Mark R. WilligVice President, Sales

• 
  SEC EDGAR Submission 0001047469-05-010150 - [Cached Version]
  Published on: 4/14/2005    Last Visited: 4/16/2005  

  Mark R. Willig
  ...
  Mark R. Willig has served as Senior Vice President, Sales and Marketing since January 2005.From July 2002 through January 2005, Mr. Willig served as our Vice President of Sales.Prior to joining Specialty, Mr. Willig served as Vice President of Sales at Myriad Genetics from 1997 to July 2002.He also served as Vice President of Sales and Marketing for Orca Medical Systems from 1995 to 1997.During his tenure from 1984 to 1995 at Abbott Diagnostics, a division of Abbott Laboratories, Mr. Willig held a variety of field sales and sales management responsibilities, including leadership of Abbott's integrated health systems sales force.Mr. Willig received his B.A. in Speech Communications from the University of Missouri.

• 
  Specialty Laboratories - News Release - [Cached Version]
  Published on: 7/23/2002    Last Visited: 2/22/2006  

  Specialty Laboratories Names New Vice President of Sales; Mark R. Willig to Lead Sales Expansion in the Hospital MarketSpecialty Laboratories - News Release
  ...
  Specialty Laboratories Names New Vice President of Sales; Mark R. Willig to Lead Sales Expansion in the Hospital Market
  
  SANTA MONICA, Calif., Jul 23, 2002 (BUSINESS WIRE) -- Specialty Laboratories, Inc. (NYSE:SP) (Specialty), a leading research-driven clinical reference laboratory, announced today the appointment of Mark R. Willig to the position of Vice President, Sales.The appointment supports Specialty's current focus on revitalizing its leadership position in the hospital market following the resolution of regulatory sanctions announced on July 17, 2002.
  
  Willig, 43, is a seasoned sales-professional with nearly two decades of experience in the diagnostics and clinical reference laboratory industries.As Vice President of Sales at Myriad Genetics from 1997 until joining Specialty, Willig developed and managed a national field sales organization charged with the promotion of esoteric gene-based tests for predisposition to cancer and other diseases.From 1995 to 1997 he served as Vice President of Sales and Marketing for Orca Medical Systems, a hospital information technology company.During his tenure from 1984 to 1995 at Abbott Diagnostics, a division of Abbott Laboratories, Willig held a variety of field sales and sales management responsibilities, including leadership of Abbott's integrated health systems sales force.
  ...
  "My decision to join the Specialty team was directly influenced by the company's wholly esoteric focus, excellence in new assay development and proprietary solutions for client connectivity," noted Willig.

Page:  1 2